eli lilly news - Search News

The Motley Fool on MSN · 1d

Prediction: This Will be Eli Lilly's Next Big Move.

Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring sales thanks to its dominance in the high-growth weight loss drug market. This is thanks to Lilly's dominance in the billion-dollar weight loss drug market.

Zacks.com on MSN · 3d

Eli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?

Eli Lilly and Company’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The stock has also outperformed the sector as well as the S&P 500 as seen in the chart below.

MarketWatch on MSN · 23h

Eli Lilly & Co. stock rises Thursday, still underperforms market

Shares of Eli Lilly & Co. LLY advanced 1.11% to $915.04 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 and the Dow Jones Industrial Average DJIA rising 1.26% to 42,025.19. The stock's rise snapped a four-day losing streak.

4h

Eli Lilly: I Admit Defeat As I Understated Its Growth Prospects (Upgrade)

Eli Lilly's valuation is a critical concern, but its robust execution has improved its ability to actualize its high-growth ...

2d

Eli Lilly urges court to toss $183 mln Medicaid fraud judgment

Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...

2d

Eli Lilly (NYSE:LLY) Gains FDA Approval for EBGLYSS, Expands Strategic Alliances for Market Growth

Eli Lilly(NYSE:LLY) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights ...

10d

Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’

Good morning. Eli Lilly and Company has promoted longtime executive Lucas Montarce to the role of CFO. The move is similar to ...

Eli Lilly request records of people who took copies of its weight-loss drug

The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell ...

12d

Beyond Mounjaro and Zepbound: 6 Other Drugs That Could Be Blockbusters for Eli Lilly

Lilly clearly has an abundance of growth drivers -- and the list includes more than Mounjaro, Zepbound, and the six drugs ...

New eczema drug from Eli Lilly receives FDA approval for children and adults

On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 and ...

5hon MSN

Lilly asks people who took compounded tirzepatide for their medical records

Eli Lilly is requesting medical records from patients who took compounded versions of tirzepatide amid safety concerns and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results